Jaguar Health, Inc. (JAGX): debt financing — Jaguar Health raises $3.45M via convertible notes; CEO & insiders participate

Jaguar Health, Inc.

$3.448M aggregate principal convertible notes at 6% interest, 3-month maturity, convertible into common stock at ~$5.54/share.
Insiders (CEO Conte, CFO, board members) purchase $535K of notes, also receive warrants at $5.43 exercise price.
Warrants exercisable immediately, expire in 5 years; up to 622,598 warrant shares plus 622,598 conversion shares.
Proceeds for working capital; H.C. Wainwright placement agent with 7% cash fee and warrants.
Expected close March 27, 2025; registration rights agreement requires filing by April 15, 2025.

item 1.01 item 2.03 item 3.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Jaguar Health, Inc. incurred convertible notes of approximately $3.4 million aggregate principal amount with selected accredited investors at 6% per annum maturing three months after issuance.

Instrument: convertible notes
Principal: approximately $3.4 million aggregate principal amount
Counterparty: selected accredited investors
Rate: 6% per annum
Maturity: three months after issuance
Event: incurrence

Exact text from the filing

On March 26, 2025 (the “Execution Date”), Jaguar Health, Inc. (the “Company”) entered into securities purchase agreements (the “Securities Purchase Agreements”) with selected accredited investors (each, an “Investor”), pursuant to which the Company, in a private placement (the “Private Placement”), will issue approximately $3.4 million aggregate principal amount of convertible promissory notes (collectively, the “Notes”) to such Investors.

View on SEC.gov

24 debt financings filed in the last 30 days. Browse all debt financings →

Jaguar Health, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-044842

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.